Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3.
about
Neuronal networks in mental diseases and neuropathic pain: Beyond brain derived neurotrophic factor and collapsin response mediator proteinsProteomic and Microscopic Strategies towards the Analysis of the Cytoskeletal Networks in Major Neuropsychiatric DisordersProteomics Research in SchizophreniaApproaches for targeted proteomics and its potential applications in neuroscienceRecent advances in quantitative neuroproteomicsPhenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis.Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development.Chronic overload of SEPT4, a parkin substrate that aggregates in Parkinson's disease, causes behavioral alterations but not neurodegeneration in miceAdvancing biomarker research: utilizing 'Big Data' approaches for the characterization and prevention of bipolar disorder.Glucocorticoid receptor 1B and 1C mRNA transcript alterations in schizophrenia and bipolar disorder, and their possible regulation by GR gene variants.Proteomic analysis of human hippocampus shows differential protein expression in the different hippocampal subfields.Gene-environment interactions and obesity traits among postmenopausal African-American and Hispanic women in the Women's Health Initiative SHARe Study.Diminished serum repetin levels in patients with schizophrenia and bipolar disorderTranscriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder.The use of clinical and biological characteristics to predict outcome following First Episode Psychosis.MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia.Quantitative proteomic and genetic analyses of the schizophrenia susceptibility factor dysbindin identify novel roles of the biogenesis of lysosome-related organelles complex 1.Schizophrenia as a disorder of social communication.Recent advances in applying mass spectrometry and systems biology to determine brain dynamics.Dysregulated 14-3-3 Family in Peripheral Blood Leukocytes of Patients with Schizophrenia.The proteome of schizophrenia.Proteomic profiling in schizophrenia: enabling stratification for more effective treatment.Omega-3 fatty acid deficiency disrupts endocytosis, neuritogenesis, and mitochondrial protein pathways in the mouse hippocampus.Evolution of complexity in the zebrafish synapse proteome.Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?Brain asymmetry: both sides of the story.Proteomic approaches to unravel the complexity of schizophrenia.Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders.Role of proteomics in biomarker discovery and psychiatric disorders: current status, potentials, limitations and future challenges.Systems biology, bioinformatics, and biomarkers in neuropsychiatry.The use of proteomic biomarkers for improved diagnosis and stratification of schizophrenia patients.Technological advances for deciphering the complexity of psychiatric disorders: merging proteomics with cell biology.Proteome and pathway effects of chronic haloperidol treatment in mouse hippocampus.CRMPs: critical molecules for neurite morphogenesis and neuropsychiatric diseases.Proteome effects of antipsychotic drugs: Learning from preclinical models.Effect of social interactions on hippocampal protein expression in animal dominant and submissive model of behavioral disorders.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms.Psychiatric disorders biochemical pathways unraveled by human brain proteomics.Proteomics insight into psychiatric disorders: an update on biological fluid biomarkers.Extracellular matrix proteomics in schizophrenia and Alzheimer's disease.
P2860
Q26750915-EB854B4B-43C8-4605-8389-E8CCD8D83186Q26750966-774B981B-B9A2-4761-9637-1DC6441D01CFQ26766821-5CB664E5-619E-4FFF-A1F1-C68524B4F29BQ26786427-8ECED35F-4B91-41BF-9D6A-54314A0ECE4EQ27000073-3578F74D-8263-4CD0-A08F-733563C00ECEQ30009226-7803CABE-2B2E-48CF-B434-C0B85A682D1BQ30435550-89BD5EBD-4ED2-4C4A-A0B0-64CDD230541EQ30450371-CFE01DDC-DEDE-4A0F-9159-939FB1BFA7D4Q30713152-3BF42E5B-FCE1-45C3-B603-1AA8469AF701Q34199632-237741FA-9635-4E6C-9378-49680F096982Q34307297-197707F2-2E54-4BE9-9934-A07441A66A74Q34314297-C8BC93CA-A93B-4CC5-BEE9-ACF424A33D87Q35004034-FC31500B-6759-49DE-BBDD-B974F6B064E5Q35079675-939097F0-406A-474F-8BF6-6539CE1C6DA9Q35457414-0F5B1ADC-B1F0-492D-A427-759F08B6B288Q35598966-0F4DDEE7-9781-4C8E-BDE1-7D3FE9C82290Q35856391-E45E6A39-DC08-4A40-854E-0C8A8B95C0ADQ36168287-1731F508-3574-4BE4-8D87-923082E03BE3Q36379339-5D78C7E2-4E47-4D65-8894-1CD445702894Q36748153-4C235054-7CA5-4496-81A2-606502CF89B6Q36848272-9BC1F758-9D8D-4207-906E-F9EDED33AB87Q36998471-FA57BF1A-66B7-44A3-A1EC-8DEC249B7B93Q37258674-45F1813D-E243-437E-8C4F-77830A6E05D9Q37681782-2EBE49BA-F05E-431E-81E8-3351419D7841Q37944127-7473B58C-0DF0-4149-AAB6-0FB67C69009FQ37956662-6285CCAD-08C8-411A-B39E-208233E17A01Q37980246-926CF6F7-55E0-417E-9A8C-62A374EAFD53Q38019745-596B2CEA-43B7-4FAE-9E23-78E77D5EBAF3Q38027217-45303234-E726-4402-A9E8-3EAACF090F60Q38069972-97892A7D-72B8-4871-9B18-AC800250AA6BQ38170139-7018ABFC-8E3B-4540-AC9D-E4BBF9A782ECQ38187682-726C1911-7FAB-43BD-80A9-16AB8B769F67Q38399332-14A99CCF-0929-4328-91D0-D478833B6C0FQ38528533-6A671C01-7462-4F08-8F39-2C70E4B684F5Q38628112-09945636-4C24-4178-9156-70EB0107DB3AQ38692694-C8AF501A-5C1C-46B4-9DF0-A880D3264909Q38805367-5DA1F4F5-F0B6-4C75-AD15-57EB5EB070C5Q38885740-A133085E-5B9E-4223-B2F1-F8FD6775F34DQ38939217-2CEEF7D2-FD90-4E3B-9FD2-8735A8B1B1EBQ38947884-0A365F49-8AE3-4534-8A15-5460F9592ADC
P2860
Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Common proteomic changes in th ...... cornu ammonis regions 2 and 3.
@ast
Common proteomic changes in th ...... cornu ammonis regions 2 and 3.
@en
type
label
Common proteomic changes in th ...... cornu ammonis regions 2 and 3.
@ast
Common proteomic changes in th ...... cornu ammonis regions 2 and 3.
@en
prefLabel
Common proteomic changes in th ...... cornu ammonis regions 2 and 3.
@ast
Common proteomic changes in th ...... cornu ammonis regions 2 and 3.
@en
P2093
P1433
P1476
Common proteomic changes in th ...... cornu ammonis regions 2 and 3
@en
P2093
Jane A English
K Oliver Schubert
Melanie Föcking
Michael J Dunn
Patrick Dicker
P304
P356
10.1001/ARCHGENPSYCHIATRY.2011.43
P407
P577
2011-05-01T00:00:00Z